Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16551763 | 1.00 | ALDH1A1 (0.39) | ALDH1A1HSD17B10THRBCES2CES1 | |
| SCHEMBL789200 | 1.00 | ALDH1A1 (0.39) | ALDH1A1HSD17B10THRBCES2CES1 | |
| SCHEMBL7203910 | 1.00 | ALDH1A1 (0.39) | ALDH1A1HSD17B10THRBCES2CES1 | |
| SCHEMBL893497 | 1.00 | ALDH1A1 (0.39) | ALDH1A1HSD17B10THRBCES2CES1 | |
| SCHEMBL9119956 | 1.00 | ALDH1A1 (0.39) | ALDH1A1HSD17B10THRBCES2CES1 | |
| SCHEMBL15353382 | 1.00 | ALDH1A1 (0.39) | ALDH1A1HSD17B10THRBCES2CES1 | |
| SCHEMBL893278 | 0.95 | ALDH1A1 (0.36) | ALDH1A1HSD17B10THRBCES2CES1 | |
| SCHEMBL29875012 | 0.95 | ALDH1A1 (0.36) | ALDH1A1HSD17B10THRBCES2CES1 | |
| SCHEMBL29957547 | 0.95 | ALDH1A1 (0.36) | ALDH1A1HSD17B10THRBCES2CES1 | |
| SCHEMBL893491 | 0.95 | ALDH1A1 (0.42) | ALDH1A1HSD17B10THRBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4417180-A2 | THERMO-ACTIVE COMPOSITE DENTAL COMPOSITION | VOCO GmbH (DE) | 2024-08-21 | — | — | EP | claimed |
| EP-3810064-B1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GMBH (DE) | 2024-05-29 | — | — | EP | claimed |
| US-11944692-B2 | Thermoactive dental composite composition | VOCO GMBH (DE) | 2024-04-02 | — | — | US | claimed |
| US-12318459-B2 | Thermoactive dental composite composition | VOCO GMBH (DE) | 2025-06-03 | — | — | US | disclosed |
| US-20240293290-A1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GMBH (DE) | 2024-09-05 | — | — | US | disclosed |
| EP-4417180-A2 | THERMO-ACTIVE COMPOSITE DENTAL COMPOSITION | VOCO GmbH (DE) | 2024-08-21 | — | — | EP | disclosed |
| EP-3810064-B1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GMBH (DE) | 2024-05-29 | — | — | EP | disclosed |
| US-11944692-B2 | Thermoactive dental composite composition | VOCO GMBH (DE) | 2024-04-02 | — | — | US | disclosed |
| EP-3810064-A1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GmbH (DE) | 2021-04-28 | — | — | EP | disclosed |
| WO-2019243339-A1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GMBH (DE) | 2019-12-26 | — | — | WO | disclosed |
| EP-2623086-B1 | Curable mixture comprising plasticisers with a polyalicyclic structure element for use in the production of dental materials. | VOCO GMBH (DE) | 2019-07-10 | — | — | EP | disclosed |
| US-9079828-B2 | Polymerizable compounds comprising a polyalicylic structure element | VOCO GMBH (DE) | 2015-07-14 | — | — | US | disclosed |
| US-8697772-B2 | Polymerizable phosphoric acid derivatives comprising a polyalicylic structure element | VOCO GMBH (DE) | 2014-04-15 | — | — | US | disclosed |
| EP-2623086-A2 | Curable mixture comprising plasticisers with a polyalicyclic structure element for use in the production of dental materials. | VOCO GmbH (DE) | 2013-08-07 | — | — | EP | disclosed |
| EP-2436668-B1 | Polymerisable compounds comprising a polyalicyclic structure element | VOCO GMBH (DE) | 2012-09-12 | — | — | EP | disclosed |
| US-20120115108-A1 | POLYMERIZABLE PHOSPHORIC ACID DERIVATIVES COMPRISING A POLYALICYLIC STRUCTURE ELEMENT | VOCO GMBH (DE) | 2012-05-10 | — | — | US | disclosed |
| EP-2450025-A1 | Polymerisable phosphoric acid derivatives comprising a polyalicyclic structure element | VOCO GmbH (DE) | 2012-05-09 | — | — | EP | disclosed |
| US-20120082959-A1 | Polymerizable Compounds Comprising a Polyalicylic Structure Element | VOCO GMBH (DE) | 2012-04-05 | — | — | US | disclosed |
| EP-2436668-A1 | Polymerisable compounds comprising a polyalicyclic structure element | VOCO GmbH (DE) | 2012-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240293290-A1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | PUF60, POLQ, F10 | ALDH1A1 1414/4885HSD17B10 2755/4885THRB 4503/4885 |
| US-12318459-B2 | Thermoactive dental composite composition | PUF60, POLQ, F10 | ALDH1A1 1414/4885HSD17B10 2755/4885THRB 4503/4885 |
| US-20120082959-A1 | Polymerizable Compounds Comprising a Polyalicylic Structure Element | PCBP1, PUF60, PARG | ALDH1A1 3882/4885HSD17B10 4481/4885THRB 4037/4885 |
| US-11944692-B2 | Thermoactive dental composite composition | PUF60, POLQ, F10 | ALDH1A1 1414/4885HSD17B10 2755/4885THRB 4503/4885 |
| US-20120115108-A1 | POLYMERIZABLE PHOSPHORIC ACID DERIVATIVES COMPRISING A POLYALICYLIC STRUCTURE ELEMENT | CAD, PCBP1, PPIP5K2 | ALDH1A1 2866/4885HSD17B10 4722/4885THRB 3418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.